Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioM Venture Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 4
Lead investments 1
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Genetics
Summary

The main office of represented VC is situated in the Martinsried. The venture was found in Europe in Germany.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BioM Venture Capital, startups are often financed by ATHOS Service. The meaningful sponsors for the fund in investment in the same round are Unternehmertum Venture Capital Partners, TransConnect, Global Life Science Ventures. In the next rounds fund is usually obtained by Unternehmertum Venture Capital Partners, Global Life Science Ventures, Gilde IT Fund.

Among the most successful fund investment fields, there are Health Care, Manufacturing. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight apceth Biopharma, Pieris AG.

The important activity for fund was in 2002. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this BioM Venture Capital performs on 38 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioM Venture Capital:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
BioM Venture Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioM Venture Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Cell Genesys California, Hayward, United States
COMTURE Japan, Tokyo
Court Square Capital Partners New York, New York, United States
Dingsheng China, Dongying, Shandong
Dongguanshi Fuhui Shiye Touzi China, Dongguang, Guangdong
Eagle Marsh Holdings Charlotte, North Carolina, United States
Honeywell Aerospace Arizona, Phoenix, United States
Invest Michigan Detroit, Michigan, United States
LGT group Liechtenstein, Vaduz, Vaduz
Maher Capital Seattle, United States, Washington
Michael Altrichter Beteiligungs GmbH Allhartsberg, Austria, Niederosterreich
New York State New York, New York, United States
Nextstage Capital Audubon, Pennsylvania, United States
Ocean Link China, Shanghai
Shanghai Xiawang Shangwu Zixun Hehuo Qiye China, Shanghai
Spark Labs New York, New York, United States
Suzhou SLAC Precision Equipment China, Jiangsu, Suzhou
The Knall Cohen Group -
Tokenomy Central, Central Region, Singapore

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

apceth Biopharma

Biotechnology
Genetics
Manufacturing
$5M04 Feb 2013 Munich, Bavaria, Germany

Dynamic Biosensors GmbH

Biopharma
Biotechnology
Health Care
Pharmaceutical
19 Dec 2012 Munich, Bavaria, Germany

Pieris AG

Biotechnology
Health Care
Medical
Pharmaceutical
$14M31 Oct 2002 Germany, Bavaria, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioM Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 9M
Peak activity year 2002
Lead investments 1
Exits 3
Group Appearance index 0.75

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

apceth Biopharma

Biotechnology
Genetics
Manufacturing
$5M04 Feb 2013 Munich, Bavaria, Germany

Dynamic Biosensors GmbH

Biopharma
Biotechnology
Health Care
Pharmaceutical
19 Dec 2012 Munich, Bavaria, Germany

Pieris AG

Biotechnology
Health Care
Medical
Pharmaceutical
$14M31 Oct 2002 Germany, Bavaria, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: